$6.42
-0.44-6.41%
Last update: 12:16 PM
15 minutes delayed
Comments
Loading...
Sana Biotechnology
SANANASDAQ
want to know what
the Bulls & Bears Say?
Sana Biotechnology (NASDAQ:SANA) Stock, Analyst Ratings, Price Targets, Forecasts
Sana Biotechnology Inc has a consensus price target of $14.67 based on the ratings of 7 analysts. The high is $34 issued by Goldman Sachs on August 6, 2021. The low is $6 issued by Goldman Sachs on November 3, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co., JMP Securities, and HC Wainwright & Co. on May 9, 2024, March 1, 2024, and March 1, 2024, respectively. With an average price target of $13 between HC Wainwright & Co., JMP Securities, and HC Wainwright & Co., there's an implied 102.49% upside for Sana Biotechnology Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
JMP Securities
Citigroup
Morgan Stanley
Goldman Sachs
1calculated from analyst ratings
Analyst Ratings for Sana Biotechnology
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/09/2024 | Buy Now | 86.92% | HC Wainwright & Co. | Emily Bodnar | → $12 | Reiterates | Buy → Buy | Get Alert |
| 03/01/2024 | Buy Now | 133.64% | JMP Securities | Reni Benjamin | $8 → $15 | Maintains | Market Outperform | Get Alert |
| 03/01/2024 | Buy Now | 86.92% | HC Wainwright & Co. | Emily Bodnar | → $12 | Reiterates | Buy → Buy | Get Alert |
| 01/16/2024 | Buy Now | 86.92% | HC Wainwright & Co. | Emily Bodnar | → $12 | Upgrade | Neutral → Buy | Get Alert |
| 10/12/2023 | Buy Now | 24.61% | JMP Securities | Reni Benjamin | $9 → $8 | Maintains | Market Outperform | Get Alert |
| 09/25/2023 | Buy Now | 40.19% | JMP Securities | Reni Benjamin | → $9 | Initiates | → Market Outperform | Get Alert |
| 09/05/2023 | Buy Now | 24.61% | Citigroup | Samantha Semenkow | → $8 | Initiates | → Buy | Get Alert |
| 08/14/2023 | Buy Now | — | TD Cowen | Marc Frahm | — | Initiates | → Market Perform | Get Alert |
| 05/02/2023 | Buy Now | — | HC Wainwright & Co. | Emily Bodnar | — | Initiates | → Neutral | Get Alert |
| 01/24/2023 | Buy Now | 102.49% | Morgan Stanley | Matthew Harrison | $15 → $13 | Maintains | Overweight | Get Alert |
| 11/03/2022 | Buy Now | -6.54% | Goldman Sachs | Salveen Richter | $7 → $6 | Maintains | Neutral | Get Alert |
| 05/17/2022 | Buy Now | 133.64% | Morgan Stanley | Matthew Harrison | $17 → $15 | Maintains | Overweight | Get Alert |
| 08/06/2021 | Buy Now | 429.6% | Goldman Sachs | — | — | Maintains | Neutral | Get Alert |
FAQ
What is the target price for Sana Biotechnology (SANA) stock?
The latest price target for Sana Biotechnology (NASDAQ:SANA) was reported by HC Wainwright & Co. on May 9, 2024. The analyst firm set a price target for $12.00 expecting SANA to rise to within 12 months (a possible 86.92% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Sana Biotechnology (SANA)?
The latest analyst rating for Sana Biotechnology (NASDAQ:SANA) was provided by HC Wainwright & Co., and Sana Biotechnology reiterated their buy rating.
When was the last upgrade for Sana Biotechnology (SANA)?
The last upgrade for Sana Biotechnology Inc happened on January 16, 2024 when HC Wainwright & Co. raised their price target to $12. HC Wainwright & Co. previously had a neutral for Sana Biotechnology Inc.
When was the last downgrade for Sana Biotechnology (SANA)?
There is no last downgrade for Sana Biotechnology.
When is the next analyst rating going to be posted or updated for Sana Biotechnology (SANA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sana Biotechnology, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sana Biotechnology was filed on May 9, 2024 so you should expect the next rating to be made available sometime around May 9, 2025.
Is the Analyst Rating Sana Biotechnology (SANA) correct?
While ratings are subjective and will change, the latest Sana Biotechnology (SANA) rating was a reiterated with a price target of $12.00 to $12.00. The current price Sana Biotechnology (SANA) is trading at is $6.42, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.